Rapport Therapeutics, Inc. Preferred Stock, Dividend Rate, Percentage
Rapport Therapeutics, Inc. (RAPP) reported Preferred Stock, Dividend Rate, Percentage of 8.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Stockholders' Equity Note › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockDividendRatePercentage · last filed 2026-03-10
- Rapport Therapeutics, Inc. preferred stock, dividend rate, percentage for the quarter ending 2025-03-31 was 8.00%.
- Rapport Therapeutics, Inc. preferred stock, dividend rate, percentage for fiscal 2025 was 8.00%, a 0.00% change from fiscal 2024.
- Rapport Therapeutics, Inc. preferred stock, dividend rate, percentage for fiscal 2024 was 8.00%.
| Period end | Preferred Stock, Dividend Rate, Percentage 3 month | Preferred Stock, Dividend Rate, Percentage 6 month | Preferred Stock, Dividend Rate, Percentage 9 month | Preferred Stock, Dividend Rate, Percentage 12 month |
|---|---|---|---|---|
| 2025-12-31 | 8.00% 10-K · filed 2026-03-10 | |||
| 2025-09-30 | 8.00% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 8.00% 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 8.00% 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 8.00% 10-K · filed 2025-03-11 | |||
| 2024-09-30 | 8.00% 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 8.00% 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |